**Background:** Dry eye disease, particularly aqueous-deficient dry eye, is often caused by chronic inflammation of the lacrimal gland (LG) in conditions like Sjögren's syndrome (SS). Inflammasomes are intracellular complexes that activate inflammatory cytokines IL-1β and IL-18 and can induce pyroptosis. While aberrant inflammasome activation is implicated in autoimmune diseases, its role in LG inflammation and the potential involvement of lipid metabolism in resolving inflammation were not well understood. This study aimed to characterize inflammasome activation during acute and chronic LG inflammation and identify metabolic pathways that may regulate the resolution of inflammation.
**Methods:** The authors used multiple mouse models: (1) R26^ASC-citrine^ reporter mice to visualize inflammasome formation via fluorescent ASC specks; (2) acute injury induced by intraglandular injection of IL-1α; (3) bacterial mimicry using LPS/nigericin injection; (4) chronic inflammation models including NOD.H2^b^ mice (a primary SS model) and TSP-1^-/- mice. Inflammasome activation was assessed by immunostaining for ASC specks, Western blotting for CASP1, IL-1β, and GSDMD cleavage, and qRT-PCR. RNA-seq data from acute injury (GSE99093) and chronic inflammation (GSE210332) were analyzed for differentially expressed genes (DEGs) and pathway enrichment using Metascape and ROSALIND software. Lipid metabolism genes were specifically examined during the resolution phase (day 3 post-injury) and in chronically inflamed LGs.
**Key Results:**
- In R26^ASC-citrine^ mice, LPS/nigericin injection induced numerous ASC specks in LG epithelial cells (acinar cells, myoepithelial cells, and ducts) within 6 hours. Similarly, IL-1α injection led to ASC speck formation at 6 hours, with increased speck number and diameter by 12 hours, accompanied by nuclear fragmentation indicative of cell death.
- In chronically inflamed NOD.H2^b^ LGs (6-month-old males), Western blotting showed increased cleaved CASP1 (p33), mature IL-1β (17 kDa), and a ~5-fold increase in cleaved GSDMD compared to BALBc controls. TSP-1^-/-:R26^ASC-citrine^ mice also showed significantly more ASC specks at 2 and 6 months, with numbers increasing with disease progression.
- RNA-seq analysis of acute injury revealed upregulation of inflammasome sensors Nlrp3, Aim2, Ifi204, Mefv, Naip5, and caspases Casp1 and Casp4 on days 1-2, returning to basal levels by day 3. In chronic NOD.H2^b^ LGs, these same sensors plus Nlrc4 were upregulated from 2 months of age, with further increases at 4 months. Il1b and Il18 were significantly elevated in both models.
- Pathway analysis of day 3 post-injury (resolution phase) identified 66 genes specifically upregulated, with the most significant cluster being "Cholesterol metabolism with Bloch and Kandutsch-Russell pathways" (18 genes). Key lipogenic genes included Srebf1 (encoding SREBP-1), Acacb, Sqle, and Acss2, peaking on day 3.
- In contrast, chronically inflamed NOD.H2^b^ LGs showed downregulation of PPARα (Ppara), Srebf1, and genes for fatty acid biosynthesis (Acacb) and mitochondrial β-oxidation, while cholesterol biosynthesis genes (Hmgcr, Sqle, Soat1/2) were upregulated. These changes were evident as early as 2 months of age.
**Clinical Implications:** This study provides direct evidence that LG epithelial cells act as sentinel cells by forming inflammasomes in response to microbial and sterile stimuli, and that sustained inflammasome activation contributes to chronic inflammation in SS models. The discovery that lipid metabolism shifts from fatty acid synthesis (promoting resolution) to cholesterol accumulation (promoting inflammation) during chronic disease suggests a metabolic mechanism driving LG dysfunction. The authors propose that PPARα activators like fenofibrate, which can restore fatty acid β-oxidation and reduce inflammation, combined with anti-inflammatory agents targeting IL-1 or GSDMD, may offer new therapeutic strategies for SS-associated dry eye disease. These findings highlight the importance of epithelial cell metabolism in regulating immune responses and tissue regeneration in the lacrimal gland.